A Phase II Multicenter Study of Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Lenalidomide (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 11 Jun 2017 Last checked against ClinicalTrials.gov.
- 20 Dec 2016 Status changed from active, no longer recruiting to completed.
- 07 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.